Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ganglioneuroblastoma × fludarabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia, Myeloid, Acute 239 Precursor Cell Lymphoblastic Leukemia-Lymphoma 144 Myelodysplastic Syndromes 141 Leukemia, Lymphocytic, Chronic, B-Cell 140 Leukemia 127 Multiple Myeloma 118 Lymphoma 115 Lymphoma, Non-Hodgkin 110 Recurrence 79 Hematologic Neoplasms 76 Melanoma 67 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 67 Hodgkin Disease 67 Lymphoma, B-Cell 59 Lymphoma, Mantle-Cell 51 Lymphoma, Large B-Cell, Diffuse 50 Lymphoma, Follicular 50 Burkitt Lymphoma 41 Neoplasms 39 Myeloproliferative Disorders 39 Ovarian Neoplasms 38 Neoplasm Metastasis 33 Lymphoma, B-Cell, Marginal Zone 30 Neoplasms, Plasma Cell 28 Graft vs Host Disease 27 Breast Neoplasms 27 Carcinoma, Non-Small-Cell Lung 26 Leukemia, Biphenotypic, Acute 25 Primary Myelofibrosis 24 Anemia, Refractory, with Excess of Blasts 22

Interventions

Cyclophosphamide 8 dinutuximab 7 Magnetic Resonance Spectroscopy 7 Topotecan 6 Doxorubicin 6 sargramostim 5 Vincristine 5 Stem Cell Transplantation 5 Radiation 5 Platinum 5 Melphalan 5 Isotretinoin 5 Colony-Stimulating Factors 5 Cisplatin 5 Biopsy 5 1,2-diaminocyclohexaneplatinum II citrate 5 Temozolomide 4 Specimen Handling 4 Irinotecan 4 Etoposide 4 Congresses as Topic 4 Carboplatin 4 Thiotepa 3 Busulfan 3 3-Iodobenzylguanidine 3 etoposide phosphate 2 Razoxane 2 Dexrazoxane 2 temsirolimus 1 lorlatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07502287 2026-03-30

DUAL-NK-NB

Beijing Biotech

Phase 1/2 Recruiting

Neuroblastoma, Recurrence, Ganglioneuroblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡